Contact
  • About Us
    • Retour
    • About Us
    • Track-Record
    • Mission and Vision
    • Our team
    • Our scientific commitee
  • Preclinical services
    • Retour
    • Preclinical services
    • In vitro preclinical services
      • Retour
      • In vitro Endpoint studies
      • In vitro continuous-monitoring studies
      • Sample Characterisation
    • Ex vivo preclinical services
    • In vivo preclinical services
    • Preclinical development of immunotherapies
  • Tumour models
    • Retour
    • Tumour models
    • Syngeneic tumour models
    • Cell-Derived Xenografts
    • Patient-Derived Xenografts
    • Original preclinical resistant tumour models
  • Our strengths
    • Retour
    • Our strengths
    • Facilities & ressources
    • Equipment
    • Network & Partners
  • News & Events
    • Retour
    • News & Events
    • News
    • Corporate Presentation
    • Press Release
    • Posters
    • Events
    • Upcoming Events
  • Publications
  • Careers

Press Release

Home > Press Release

May 10, 2023 - Article La Gazette du Laboratoire
April 11, 2023 - Eurostars-funded REPRINT consortium reaches milestones with evidence of complete tumor regression induced by dendritic cell reprogramming
Antineo chooses Repositive’s Cancer Models product to share cancer models with more oncology researchers
Tumour models
  • Cell-Derived Xenografts
  • Syngeneic tumour models
  • Original preclinical resistant tumour models
  • Patient-Derived Xenografts
Preclinical services
  • In vitro preclinical services
  • ex vivo preclinical services
  • in vivo preclinical services
  • Preclinical development of immunotherapies
Our strengths
  • Facilities & ressources
  • Equipment
  • Network & Partners
Contact & News
  • Contact us
  • News & Events
  • Publication
  • Legals
We use cookies to guarantee you the best experience on our websiteOkNoPrivacy policy
 Revoke consent